RASILEZ HCTZ Trademark

Trademark Overview


On Thursday, March 1, 2007, a trademark application was filed for RASILEZ HCTZ with the United States Patent and Trademark Office. The USPTO has given the RASILEZ HCTZ trademark a serial number of 77119659. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, November 17, 2008. This trademark is owned by Novartis AG. The RASILEZ HCTZ trademark is filed in the Pharmaceutical Products category with the following description:

Diagnostic preparations for medical and veterinary use, pharmaceutical preparations for the treatment of and prevention of disorders of the nervous system, the immune system, the cardio-vascular system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, diabetes and metabolic diseases, for use in dermatology, in oncology, in hematology, in transplantation, in ophthalmology, for use in the gastroenterological area and in the prevention and treatment of ocular disorders and diseases, pharmaceutical preparations for treating bacteria-based diseases, anti-infectives, anti-bacterials, antivirals, anti-biotics, anti-fungals, vaccines, all of the foregoing containing hydrochlorothiazide (HCTZ)
rasilez hctz

General Information


Serial Number77119659
Word MarkRASILEZ HCTZ
Filing DateThursday, March 1, 2007
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, November 17, 2008
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 24, 2007

Trademark Statements


Disclaimer with Predetermined TextHCTZ
Goods and ServicesDiagnostic preparations for medical and veterinary use, pharmaceutical preparations for the treatment of and prevention of disorders of the nervous system, the immune system, the cardio-vascular system, the respiratory system, the musculo-skeletal system, the genitourinary system, for the treatment of inflammatory disorders, diabetes and metabolic diseases, for use in dermatology, in oncology, in hematology, in transplantation, in ophthalmology, for use in the gastroenterological area and in the prevention and treatment of ocular disorders and diseases, pharmaceutical preparations for treating bacteria-based diseases, anti-infectives, anti-bacterials, antivirals, anti-biotics, anti-fungals, vaccines, all of the foregoing containing hydrochlorothiazide (HCTZ)

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, March 6, 2007
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNovartis AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBasel
CH

Party NameNovartis AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBasel
CH

Trademark Events


Event DateEvent Description
Monday, November 17, 2008ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, November 17, 2008ABANDONMENT - NO USE STATEMENT FILED
Tuesday, April 1, 2008EXTENSION 1 GRANTED
Tuesday, April 1, 2008EXTENSION 1 FILED
Tuesday, April 1, 2008TEAS EXTENSION RECEIVED
Thursday, October 25, 2007ASSIGNED TO EXAMINER
Tuesday, October 16, 2007NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 24, 2007PUBLISHED FOR OPPOSITION
Wednesday, July 4, 2007NOTICE OF PUBLICATION
Wednesday, June 20, 2007LAW OFFICE PUBLICATION REVIEW COMPLETED
Wednesday, June 20, 2007ASSIGNED TO LIE
Tuesday, May 22, 2007APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, May 11, 2007EXAMINER'S AMENDMENT ENTERED
Friday, May 11, 2007EXAMINERS AMENDMENT E-MAILED
Friday, May 11, 2007EXAMINERS AMENDMENT -WRITTEN
Monday, May 7, 2007NON-FINAL ACTION E-MAILED
Monday, May 7, 2007NON-FINAL ACTION WRITTEN
Thursday, April 26, 2007ASSIGNED TO EXAMINER
Tuesday, March 6, 2007NEW APPLICATION ENTERED IN TRAM